Chad M. Cohen's most recent trade in Grindr Inc - Ordinary Shares - Class A was a trade of 13,593 Common Stock done . Disclosure was reported to the exchange on June 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 13,593 | 24,547 | - | 0 | Common Stock | |
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 4,049 | 28,596 | - | 0 | Common Stock | |
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2025 | 221 | 10,954 | - | 0 | Common Stock | |
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 9,336 | 10,733 | - | 0 | Common Stock | |
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 1,397 | 1,397 | - | 0 | Common Stock | |
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2025 | 38,538 | 0 | - | - | Class A Common Stock | |
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 30 Apr 2025 | 8,158 | 38,538 | - | - | Class A Common Stock | ||
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 30 Apr 2025 | 8,158 | 0 | - | - | Vacasa Holdings Units | ||
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 30 Apr 2025 | 8,158 | 0 | - | - | Vacasa Employee Holdings LLC Interests | ||
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 30 Apr 2025 | 8,158 | 8,158 | - | - | Vacasa Holdings Units | ||
| Grindr Inc (Class A) | Chad M. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 9,336 | 10,733 | - | 0 | Common Stock | |
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 21 May 2024 | 20,134 | 30,380 | - | 0 | Class A Common Stock | ||
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 23 May 2023 | 170,940 | 204,939 | - | 0 | Class A Common Stock | ||
| Vacasa Inc Ordinary Shares | Chad M. Cohen | Director | 24 May 2022 | 33,999 | 33,999 | - | 0 | Class A Common Stock | ||
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 22 Dec 2021 | 10,000 | 31,604 (0%) | 0% | 7.3 | 72,700 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2021 | 10,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Dec 2021 | 10,000 | 21,604 (0%) | 0% | 30 | 300,000 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.03 per share. | 09 Nov 2021 | 5,000 | 21,604 (0%) | 0% | 36.0 | 180,150 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 5,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 5,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 09 Nov 2021 | 5,000 | 21,604 (0%) | 0% | 33.9 | 169,650 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Nov 2021 | 5,000 | 26,604 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 09 Nov 2021 | 5,000 | 26,604 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.51 per share. | 05 Oct 2021 | 5,000 | 21,604 (0%) | 0% | 32.5 | 162,550 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 5,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 5,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.30 per share. | 05 Oct 2021 | 5,000 | 21,604 (0%) | 0% | 32.3 | 161,500 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 05 Oct 2021 | 5,000 | 26,604 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 05 Oct 2021 | 5,000 | 26,604 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 07 Sep 2021 | 9,375 | 30,979 (0%) | 0% | 6.5 | 61,406 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 9,375 | 65,625 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.71 per share. | 07 Sep 2021 | 9,375 | 21,604 (0%) | 0% | 39.7 | 372,281 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 5,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.01 per share. | 07 Sep 2021 | 5,000 | 21,604 (0%) | 0% | 39.0 | 195,050 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 07 Sep 2021 | 5,000 | 26,604 (0%) | 0% | 7.3 | 36,350 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 10 Aug 2021 | 10,000 | 31,604 (0%) | 0% | 6.6 | 65,500 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 10,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 10 Aug 2021 | 8,738 | 22,866 (0%) | 0% | 33.5 | 292,548 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 10 Aug 2021 | 5,000 | 26,604 (0%) | 0% | 6.6 | 32,750 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 10 Aug 2021 | 5,000 | 21,604 (0%) | 0% | 35 | 175,000 | Common Stock |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 5,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Chad M. Cohen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.47 per share. | 10 Aug 2021 | 1,262 | 21,604 (0%) | 0% | 34.5 | 43,501 | Common Stock |